Post-translational modifications regulate signalling by Ror1

Acta Physiologica

Volumn 203, Issue 3, 2011, Pages 351-362

  Kaucka M ^a   Krejci P ^a,b,c   Plevova K ^d   Pavlová, Š ^d   Prochazkova J ^a,b   Janovska P ^a   Valnohova J ^a   Kozubik A ^a,b   Pospíšilová, Š ^d   Bryja, V ^a,b  

^a MASARYK UNIVERSITY   (Czech Republic)

^b INSTITUTE OF BIOPHYSICS   (Czech Republic)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Chronic lymphocytic leukaemia; Glycosylation; Post translational modification; Ror1

Indexed keywords

BREFELDIN A; CELL SURFACE PROTEIN; GLYCOPEPTIDASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY ROR1; RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR; TUNICAMYCIN; UNCLASSIFIED DRUG;

ARTICLE; CELL LYSATE; CELL STRAIN HEK293; CELL SURFACE; CELL THERAPY; CELLULAR DISTRIBUTION; CHO CELL; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FILOPODIUM; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; SIGNAL TRANSDUCTION; UBIQUITINATION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; B-LYMPHOCYTES; BLOTTING, WESTERN; CHO CELLS; CRICETINAE; CRICETULUS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLOW CYTOMETRY; GLYCOSYLATION; HEK293 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MICROSCOPY, CONFOCAL; MOLECULAR WEIGHT; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; PSEUDOPODIA; RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTORS; SIGNAL TRANSDUCTION; TRANSFECTION; UBIQUITINATION;

EID: 80053985778     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2011.02306.x     Document Type: Article

References (31)

1. Afzal, A.R., Rajab, A., Fenske, C.D., Oldridge, M., Elanko, N., Ternes-Pereira, E., Tüysüz, B., Murday, V.A., Patton, M.A., Wilkie, A.O. & Jeffery, S. 2000. Recessive Robinow syndrome, allelic to dominant brachydactyly type B, is caused by mutation of ROR2. Nat Genet 25, 419-422.
2. Akbarzadeh, S., Wheldon, L.M., Sweet, S.M., Talma, S., Mardakheh, F.K. & Heath, J.K. 2008. The deleted in brachydactyly B domain of ROR2 is required for receptor activation by recruitment of Src. PLoS ONE 3, e1873.
3. Baskar, S., Kwong, K.Y., Hofer, T., Levy, J.M., Kennedy, M.G., Lee, E., Staudt, L.M., Wilson, W.H., Wiestner, A. & Rader, C. 2008. Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia. Clin Cancer Res 14, 396-404.
4. van Bokhoven, H., Celli, J., Kayserili, H., van Beusekom, E., Balci, S., Brussel, W., Skovby, F., Kerr, B., Percin, E.F., Akarsu, N. & Brunner, H.G. 2000. Mutation of the gene encoding the ROR2 tyrosine kinase causes autosomal recessive Robinow syndrome. Nat Genet 25, 423-426.
5. Bryja, V., Schulte, G. & Arenas, E. 2007. Wnt-3a utilizes a novel low dose and rapid pathway that does not require casein kinase 1-mediated phosphorylation of Dvl to activate beta-catenin. Cell Signal 19, 610-616.
6. Clevers, H. 2006. Wnt/beta-catenin signalling in development and disease. Cell 127, 469-480.
7. Daneshmanesh, A.H., Mikaelsson, E., Jeddi-Tehrani, M., Bayat, A.A., Ghods, R., Ostadkarampour, M., Akhondi, M., Lagercrantz, S., Larsson, C., Osterborg, A., Shokri, F., Mellstedt, H. & Rabbani, H. 2008. Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy. Int J Cancer 123, 1190-1195.
8. Fukuda, T., Chen, L., Endo, T., Tang, L., Lu, D., Castro, J.E., Widhopf, G.F. 2nd, Rassenti, L.Z., Cantwell, M.J., Prussak, C.E., Carson, D.A. & Kipps, T.J. 2008. Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a. Proc Natl Acad Sci USA 105, 3047-3052.
9. Haltiwanger, R.S. & Lowe, J.B. 2004. Role of glycosylation in development. Annu Rev Biochem 73, 491-537.
10. Hikasa, H., Shibata, M., Hiratani, I. & Taira, M. 2002. The Xenopus receptor tyrosine kinase Xror2 modulates morphogenetic movements of the axial mesoderm and neuroectoderm via Wnt signalling. Development 129, 5227-5239.
11. Hudecek, M., Schmitt, T.M., Baskar, S., Lupo-Stanghellini, M.T., Nishida, T., Yamamoto, T.N., Bleakley, M., Turtle, C.J., Chang, W.C., Greisman, H.A., Wood, B., Maloney, D.G., Jensen, M.C., Rader, C. & Riddell, S.R. 2010. The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor. Blood 116, 4532-4541.
12. Krejci, P., Masri, B., Salazar, L., Farrington-Rock, C., Prats, H., Thompson, L.M. & Wilcox, W.R. 2007. Bisindolylmaleimide I suppresses fibroblast growth factor-mediated activation of Erk MAP kinase in chondrocytes by preventing Shp2 association with the Frs2 and Gab1 adaptor proteins. J Biol Chem 282, 2929-2936.
13. Lim, K.L., Chew, K.C., Tan, J.M., Wang, C., Chung, K.K., Zhang, Y., Tanaka, Y., Smith, W., Engelender, S., Ross, C.A., Dawson, V.L. & Dawson, T.M. 2005. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation. J Neurosci 25, 2002-2009.
14. MacKeigan, J.P., Murphy, L.O. & Blenis, J. 2005. Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. Nat Cell Biol 7, 591-600.
15. Minami, Y., Oishi, I., Endo, M. & Nishita, M. 2010. Ror-family receptor tyrosine kinases in noncanonical Wnt signalling: their implications in developmental morphogenesis and human diseases. Dev Dyn 239, 1-15.
16. Misumi, Y., Miki, K., Takatsuki, A., Tamura, G. & Ikehara, Y. 1986. Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes. J Biol Chem 261, 11398-11403.
17. Nishita, M., Yoo, S.K., Nomachi, A., Kani, S., Sougawa, N., Ohta, Y., Takada, S., Kikuchi, A. & Minami, Y. 2006. Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration. J Cell Biol 175, 555-562.
18. Nomi, M., Oishi, I., Kani, S., Suzuki, H., Matsuda, T., Yoda, A., Kitamura, M., Itoh, K., Takeuchi, S., Takeda, K., Akira, S., Ikeya, M., Takada, S. & Minami, Y. 2001. Loss of mRor1 enhances the heart and skeletal abnormalities in mRor2-deficient mice: redundant and pleiotropic functions of mRor1 and mRor2 receptor tyrosine kinases. Mol Cell Biol 21, 8329-8335.
19. Oishi, I., Suzuki, H., Onishi, N., Takada, R., Kani, S., Ohkawara, B., Koshida, I., Suzuki, K., Yamada, G., Schwabe, G.C., Mundlos, S., Shibuya, H., Takada, S. & Minami, Y. 2003. The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway. Genes Cells 8, 645-654.
20. Paganoni, S. & Ferreira, A. 2003. Expression and subcellular localization of Ror tyrosine kinase receptors are developmentally regulated in cultured hippocampal neurons. J Neurosci Res 73, 429-440.
21. Paganoni, S. & Ferreira, A. 2005. Neurite extension in central neurons: a novel role for the receptor tyrosine kinases Ror1 and Ror2. J Cell Sci 118, 433-446.
22. Schambony, A. & Wedlich, D. 2007. Wnt-5A/Ror2 regulate expression of XPAPC through an alternative noncanonical signalling pathway. Dev Cell 12, 779-792.
23. Schwabe, G.C., Tinschert, S., Buschow, C., Meinecke, P., Wolff, G., Gillessen-Kaesbach, G., Oldridge, M., Wilkie, A.O., Kömec, R. & Mundlos, S. 2000. Distinct mutations in the receptor tyrosine kinase gene ROR2 cause brachydactyly type B. Am J Hum Genet 67, 822-831.
24. Schwarzer, W., Witte, F., Rajab, A., Mundlos, S. & Stricker, S. 2009. A gradient of ROR2 protein stability and membrane localization confers brachydactyly type B or Robinow syndrome phenotypes. Hum Mol Genet 18, 4013-4021.
25. Seifert, J.R. & Mlodzik, M. 2007. Frizzled/PCP signalling: a conserved mechanism regulating cell polarity and directed motility. Nat Rev Genet 8, 126-138.
26. Semenov, M.V., Habas, R., Macdonald, B.T. & He, X. 2007. Snapshot: noncanonical Wnt signalling pathways. Cell 131, 1378.
27. Takatsuki, A. & Tamura, G. 1971. Effect of tunicamycin on the synthesis of macromolecules in cultures of chick embryo fibroblasts infected with Newcastle disease virus. J Antibiot (Tokyo) 24, 785-794.
28. Takeuchi, S., Takeda, K., Oishi, I., Nomi, M., Ikeya, M., Itoh, K., Tamura, S., Ueda, T., Hatta, T., Otani, H., Terashima, T., Takada, S., Yamamura, H., Akira, S. & Minami, Y. 2000. Mouse Ror2 receptor tyrosine kinase is required for the heart development and limb formation. Genes Cells 5, 71-78.
29. Wang, B., Sinha, T., Jiao, K., Serra, R. & Wang, J. 2010. Disruption of PCP signalling causes limb morphogenesis and skeletal defects and may underlie Robinow syndrome and brachydactyly type B. Hum Mol Genet 20, 271-285.
30. Witte, F., Bernatik, O., Kirchner, K., Masek, J., Mahl, A., Krejci, P., Mundlos, S., Schambony, A., Bryja, V. & Stricker, S. 2010. Negative regulation of Wnt signalling mediated by CK1-phosphorylated Dishevelled via Ror2. FASEB J 24, 2417-2426.
31. Yamamoto, H., Yoo, S.K., Nishita, M., Kikuchi, A. & Minami, Y. 2007. Wnt5a modulates glycogen synthase kinase 3 to induce phosphorylation of receptor tyrosine kinase Ror2. Genes Cells 12, 1215-1223.